| Dewpoint Therapeutics. (1/30/19). "Press Release: Dewpoint Therapeutics Launches with $60 Million Series A to Advance Proprietary Platform for Drugging Condensates". Cambridge, MA. |
2019-01-30 |
| Roche. (1/30/19). "Press Release: Roche to Discontinue Phase III CREAD 1 and 2 Clinical Studies of Crenezumab in Early Alzheimer’s Disease (AD) - other Company Programmes in AD Continue". Basel. |
2019-01-30 |
| Lonza Group Ltd.. (1/30/19). "Press Release: Lonza Announces Succession of CEO. Richard Ridinger to Retire
– Marc Funk Appointed CEO – Handover as of 1 March 2019". Basel. |
2019-01-30 |
| AC Immune S.A.. (1/30/19). "Press Release: AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimer’s Disease". Lausanne. |
2019-01-30 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Sets Offer Price at 75 Euro per Share (Adhoc-News)". |
2019-01-29 |
| Marinomed Biotech AG. (1/29/19). "Press Release: Marinomed Announces Strong Investor Demand and Expected Offer Price (Adhoc-News)". |
2019-01-29 |
| CureVac AG. (1/28/19). "Press Release: CureVac Appoints Dimitris Voliotis, M.D., Dr. med., as Chief Development Officer". Tübingen & Boston, MA. |
2019-01-28 |
| MorphoSys AG. (1/26/19). "Press Release: MorphoSys Announces That Its Patents Were Ruled Invalid in Patent Lawsuit Against Janssen and Genmab (Ad hoc)". Planegg. |
2019-01-26 |
| Genmab A/S. (1/26/19). "Press Release: Genmab Announces that the Patents Asserted against Darzalex in the United States Have Been Declared Invalid by Summary Judgment". Copenhagen. |
2019-01-26 |
| AbbVie Inc.. (1/25/19). "Press Release: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results". North Chicago, IL. |
2019-01-25 |
| Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Partners with AMPATH to Scale Up Knowledge, Skills and Training for Healthcare Providers in Kenya". Ingelheim. |
2019-01-24 |
| Boehringer Ingelheim. (1/24/19). "Press Release: Boehringer Ingelheim Launches First Veterinary Vaccines Produced in China". Ingelheim. |
2019-01-24 |
| Merck KGaA. (1/24/19). "Press Release: Merck Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors [Not intended for UK- or US-based media]". Darmstadt. |
2019-01-24 |
| BioNTech AG. (1/23/19). "Press Release: BioNTech to Acquire Antibody Generation Unit of MAB Discovery". Mainz & Munich. |
2019-01-23 |
| Clariant International AG. (1/23/19). "Press Release: Clariant Partners with ExxonMobil and Renewable Energy Group to Advance Cellulosic Biofuel Research". Muttenz, Irving, TX & Ames, IA. |
2019-01-23 |
| Marinomed Biotech AG. (1/23/19). "Press Release: Marinomed Resumes Offer Period of the IPO (Adhoc-News)". |
2019-01-23 |
| Merck KGaA. (1/23/19). "Press Release: Merck and Tencent Announce Collaboration on Intelligent Digital Healthcare Services in China". Chengdu. |
2019-01-23 |
| Sartorius AG. (1/23/19). "Press Release: Sartorius Stedim Biotech Offers Services for Characterization of New Biological Entities (NBE)". Göttingen & Glasgow. |
2019-01-23 |
| MyoKardia, Inc.. (1/23/19). "Press Release: MyoKardia Appoints William Fairey as Chief Commercial Officer". South San Francisco, CA. |
2019-01-23 |
| CRISPR Therapeutics AG. (1/22/19). "Press Release: CRISPR Therapeutics and ProBioGen Sign Collaboration and License Agreement to Develop Novel In Vivo Delivery Technologies". Cambridge, MA, Boston, MA & Berlin. |
2019-01-22 |
| Innovative Medicines Initiative (IMI). (1/22/19). "Press Release: Open Access Drug Development Tools Feature in New IMI Call for Proposals". Brussels. |
2019-01-22 |
| Scailyte AG. (1/22/19). "Press Release: Scailyte Raises CHF 2.75M in Seed Funding and Gains Swisscom Ventures and Zürcher Kantonalbank as Investors". |
2019-01-22 |
| Grünenthal GmbH. (1/22/19). "Press Release: Fabian Raschke Appointed Chief Financial Officer (CFO)". Aachen. |
2019-01-22 |
| Voyager Therapeutics, Inc.. (1/22/19). "Press Release: Voyager Therapeutics Appoints Robert Hesslein as General Counsel". Cambridge, MA. |
2019-01-22 |
| Novo Holdings A/S. (1/21/19). "Press Release: Novo Holdings Announces New Investments by REPAIR Impact Fund. Four Investments Nade in First Year, Totalling €18 Million". Copenhagen. |
2019-01-21 |
| Alnylam Pharmaceuticals, Inc.. (1/21/19). "Press Release: Alnylam Pharmaceuticals and Medison Pharma Partner to Commercialize RNAi Therapeutics in Israel". Zug & Petach Tikva. |
2019-01-21 |
| Kurma Partners. (1/21/19). "Press Release: Kurma Partners Sees Great Opportunities for Early-stage Biotech Investments in Germany and Launches Operations in Munich". Paris & Munich. |
2019-01-21 |
| Marinomed Biotech AG. (1/21/19). "Press Release: Partnership in China and EIB Financing [Not for US, AU, CA, JP or any other jurisdiction where prohibited by applicable law]". Vienna. |
2019-01-21 |
| Bruker Corporation. (1/18/19). "Press Release: Bruker Launches the G6 Leonardo for Oxygen, Nitrogen and Hydrogen (ONH) Analysis by Inert Gas Fusion". Delhi. |
2019-01-18 |
| Autifony Therapeutics Ltd.. (1/18/19). "Press Release: Autifony Therapeutics Achieves First Milestone in Agreement with Boehringer Ingelheim for a Novel Therapeutic Approach to a Range of CNS Disorders". Stevenage. |
2019-01-18 |
| Miltenyi Biotec GmbH. (1/17/19). "Press Release: Miltenyi Biotec Acquires Promising Non-harmful Imaging Process". Bergisch Gladbach. |
2019-01-17 |
| MorphoSys AG. (1/17/19). "Press Release: MorphoSys Announces that Its Licensee Janssen Has Expanded Clinical Development of Guselkumab (Tremfya) into Ulcerative Colitis". Planegg. |
2019-01-17 |
| Boehringer Ingelheim. (1/17/19). "Press Release: Boehringer Ingelheim Biopharmaceuticals China Expands Commercial Manufacturing Capacities". Shanghai. |
2019-01-17 |
| BioMed X GmbH. (1/17/19). "Press Release: BioMed X and Boehringer Ingelheim to Investigate Early Intervention in Psychiatric Diseases". Heidelberg. |
2019-01-17 |
| Qiagen N.V.. (1/16/19). "Press Release: Qiagen Receives Approval for EGFR Test in Lung Cancer as Companion Diagnostic in Japan". Hilden & Tokyo. |
2019-01-16 |
| High-Tech Gründerfonds Management GmbH. (1/16/19). "Press Release: Series-A Investment for Munich-based Medical Technology Startup Mecuris". |
2019-01-16 |
| ADC Therapeutics S.A.. (1/16/19). "Press Release: ADC Therapeutics Announces First Patient Dosed in Phase I Clinical Trial of ADCT-601 in Advanced Solid Tumors". Lausanne. |
2019-01-16 |
| Agilent Technologies Inc.. (1/16/19). "Press Release: Mala Anand to Join Agilent's Board of Directors". Santa Clara, CA. |
2019-01-16 |
| Merck KGaA. (1/16/19). "Press Release: Merck Welcomes Ten New Startups to Its Innovation Center". Darmstadt. |
2019-01-16 |
| Valneva S.E.. (1/16/19). "Press Release: Valneva Announces New $59 Million Ixiaro Supply Contract with US Government". Saint-Herblain. |
2019-01-16 |
| Tecan Group Ltd.. (1/15/19). "Press Release: Achim von Leoprechting Promoted to Become CEO of Tecan after Retirement of David Martyr". Männedorf. |
2019-01-15 |
| InterAx Biotech AG. (1/15/19). "Press Release: InterAx Biotech Closes Financing Round of CHF 3 Million and Appoints New Member of the Board". |
2019-01-15 |
| Bioharmony Therapeutics, Inc.. (1/15/19). "Press Release: Bioharmony Therapeutics and Boehringer Ingelheim Collaborate to Advance Bacteriophage Lysin Therapeutics for the Treatment of Multi-Drug Resistant Bacterial Infections". New York, NY. |
2019-01-15 |
| Bioké (Cell Signaling Technology Europe B.V.). (1/14/19). "Press Release: Bioké and OLS Omni Life Science Announce a Distribution Agreement for the BeNeLux Countries". Leiden. |
2019-01-14 |
| Qiagen N.V.. (1/14/19). "Press Release: Qiagen’s QuantiFERON-TB Gold Plus Gains Approval in Canada". Germantown, MD & Hilden. |
2019-01-14 |
| Merck KGaA [Merck Millipore]. (1/14/19). "Press Release: Merck and Roche Renew Global Distribution Agreement". |
2019-01-14 |
| Phlexglobal Ltd.. (1/14/19). "Press Release: Phlexglobal Names John McNeill as CEO". Amersham & Malvern, PA. |
2019-01-14 |
| [iito] Business Intelligence. (1/11/19). "Press Release: [iito] Discontinues Life-Sciences-UK.com
and Life-Sciences-France.com. All Data Will Still Be Available at Life-Sciences-Europe.com". Bremen. |
2019-01-11 |
| Formulatrix, Inc.. (1/10/19). "Press Release: Formulatrix Digital PCR Technology to Be Acquired by Qiagen". Bedford, MA. |
2019-01-10 |
| c-LEcta GmbH. (1/9/19). "Press Release: c-LEcta Announces Two Long-term Industry Collaborations". |
2019-01-09 |
| Sirion Biotech GmbH. (1/9/19). "Press Release: Sirion Biotech and Denali Therapeutics Join Forces to Develop Gene Therapies for Diseases of the Central Nervous System". Munich. |
2019-01-09 |
| Selexis S.A.. (1/9/19). "Press Release: Selexis Expands Strategic Immuno-Oncology Alliance with Agenus". Geneva. |
2019-01-09 |
| BC Platforms. (1/9/19). "Press Release: BC Platforms and MedEngine Announce a Strategic Partnership to Launch New Models for Global Medical Data Science Services". |
2019-01-09 |
| Curetis N.V.. (1/8/19). "Press Release: Curetis’ Subsidiary Ares Genetics Advances AI-powered Infectious Disease and Antibiotic Resistance Test". Vienna, Amsterdam & Holzgerlingen. |
2019-01-08 |
| CureVac AG. (1/8/19). "Press Release: CureVac Announces U.S. Patent Grant for mRNA Vaccination of Infants against RSV". Tübingen & Boston, MA. |
2019-01-08 |
| Sanofi S.A.. (1/7/19). "Press Release: Sanofi and Regeneron Restructure Immuno-Oncology Collaboration for Discovery and Development Programs". Paris & Tarrytown, NY. |
2019-01-07 |
| Qiagen N.V.. (1/7/19). "Press Release: Qiagen Unveils Plans for Next-generation Digital PCR Systems". Hilden & Germantown, MD. |
2019-01-07 |
| Qiagen N.V.. (1/7/19). "Press Release: Qiagen Acquires N-of-One, Expanding Its Clinical Bioinformatics Capabilities in Molecular Oncology Decision Support". Redwood City, CA & Hilden. |
2019-01-07 |
| Immunic AG. (1/7/19). "Press Release: Vital Therapies and Immunic Therapeutics Announce Transaction to Create Leading Inflammatory and Autoimmune Disease Company". San Diego, CA & Planegg-Martinsried. |
2019-01-07 |
| Eli Lilly and Company. (1/7/19). "Press Release: Lilly Announces Agreement to Acquire Loxo Oncology". Indianapolis, IN & Stamford, CT. |
2019-01-07 |
| Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Raises US$26 Million in Series B Financing Round to Accelerate Scaling as the Leading AI Drug Discovery Company". |
2019-01-07 |
| Exscientia Ltd.. (1/7/19). "Press Release: Exscientia Initiates Sixth AI Drug Discovery Partnership". |
2019-01-07 |
| Valneva S.E.. (1/7/19). "Press Release: Valneva Reports Positive Phase 1 Interim Results for Its Chikungunya Vaccine Candidate". Saint-Herblain. |
2019-01-07 |
| Valneva S.E.. (1/7/19). "Press Release: Valneva Announces Its Intention to Delist from the Vienna Stock Exchange. Trading Will Be Centralized on Euronext Paris". Saint-Herblain. |
2019-01-07 |
| Evotec AG. (1/7/19). "Press Release: Evotec Invests in Financing Round of Exscientia". Hamburg. |
2019-01-07 |
| F2G Ltd.. (1/7/19). "Press Release: F2G Expands Investor Syndicate and Progresses Phase IIb Study for Novel Antifungal". Manchester. |
2019-01-07 |
| BioMed X GmbH. (1/7/19). "Press Release: Velabs Therapeutics to Cooperate with BioMed X in the Field of Immunology". Heidelberg. |
2019-01-07 |
| Xencor, Inc.. (1/7/19). "Press Release: Xencor Regains ex-U.S. Commercial Rights to XmAb13676, CD20 x CD3 Bispecific Antibody". Monrovia, CA. |
2019-01-07 |
| Foundation Medicine, Inc.. (1/7/19). "Press Release: Foundation Medicine Announces Executive Leadership Transition". Cambridge, MA. |
2019-01-07 |
| Sophia Genetics S.A.. (1/4/19). "Press Release: Sophia Genetics Raises $77 Million to Accelerate the Democratization of Data-Driven Medicine". San Francisco, CA. |
2019-01-04 |
| CRISPR Therapeutics AG. (1/4/19). "Press Release: CRISPR Therapeutics and Vertex Announce FDA Fast Track Designation for CTX001 for the Treatment of Sickle Cell Disease". Zug, Cambridge, MA & Boston, MA. |
2019-01-04 |
| Ribon Therapeutics, Inc.. (1/4/19). "Press Release: Ribon Therapeutics Raises $65 Million to Advance Pipeline of Novel Therapeutics Targeting Cellular Stress Pathways for Cancer". Lexington, MA. |
2019-01-04 |
| Oculis S.A.. (1/4/19). "Press Release: Oculis Raises CHF15.5 Million in an Extension of Its Series B Financing Round – Total Raised CHF35.5 Million". Lausanne. |
2019-01-04 |
| Oculis S.A.. (1/4/19). "Press Release: Oculis Expands Portfolio with the In-Licensing of a Novel Phase II-stage Anti-TNF alpha Antibody Fragment". Lausanne. |
2019-01-04 |
| Boehringer Ingelheim. (1/4/19). "Press Release: Boehringer Ingelheim Exercises Option on Second Hepatic Disease Target From Research Collaboration with Dicerna". Ingelheim & Cambridge, MA. |
2019-01-04 |
| Medigene AG. (1/4/19). "Press Release: Medigene Licenses Co-stimulator to Enhance TCR Therapies for Solid Tumors". Planegg. |
2019-01-04 |
| BioNTech AG. (1/4/19). "Press Release: Sanofi Invests EUR 80m (approx. USD 91.5m) in BioNTech as Partners Extend Collaboration and Advance mRNA-based Cancer Immunotherapy into Clinical Testing against Multiple Solid Tumors". Mainz. |
2019-01-04 |
| BioNTech AG. (1/4/19). "Press Release: BioNTech Announces Corporate Form Transition from AG to SE; Welcomes Ryan Richardson as Senior Vice President Corporate Development and Strategy and Appoints Dr. Ulrich Wandschneider as Member of Supervisory Board". |
2019-01-04 |
| Galapagos N.V.. (1/4/19). "Press Release: Fibrocor and Galapagos Sign Partnership in Fibrosis". Mechelen. |
2019-01-04 |
| ADC Therapeutics S.A.. (1/4/19). "Press Release: ADC Therapeutics Doses First Patient in Phase Ib Clinical Trial of ADCT-301 in Patients with Advanced Solid Tumors". Lausanne. |
2019-01-04 |
| Biogen Inc.. (1/4/19). "Press Release: Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets". Cambridge, MA & Waltham, MA. |
2019-01-04 |
| C4 Therapeutics, Inc.. (1/4/19). "Press Release: Roche Degrader-based Medicines Collaboration. C4 Therapeutics Announces Transformation of Strategic Collaboration to Discover and Develop Degrader-based Medicines with Roche". Watertown, MA. |
2019-01-04 |
| UroGen Pharma Ltd.. (1/3/19). "Press Release: UroGen Pharma Appoints Elizabeth (Liz) Barrett as President and Chief Executive Officer". New York, NY. |
2019-01-03 |
| ProBioGen AG. (1/3/19). "Press Release: ProBioGen’s GlymaxX ADCC Enhancement Technology Used by Betta Pharmaceuticals". Berlin. |
2019-01-03 |
| Atriva Therapeutics GmbH. (1/3/19). "Press Release: Atriva Therapeutics Announces First Closing of Series A Financing Round". Tübingen. |
2019-01-03 |
| Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim and Vanderbilt University Announce Partnership to Develop Novel Therapies for Psychiatric Disorders". Nashville, TN & Ingelheim. |
2019-01-03 |
| Boehringer Ingelheim. (1/3/19). "Press Release: Boehringer Ingelheim Initiates a Collaborative Partnership with Science 37 to Accelerate Patient Centricity in the Development of Novel Therapies". Ingelheim & Playa Vista, CA. |
2019-01-03 |
| Immatics Biotechnologies GmbH. (1/3/19). "Press Release: US Patent Office Grants the 100th Patent to Immatics Underpinning the Company’s Leading Role in the Field of Innovative Immunotherapies". Munich. |
2019-01-03 |
| InflaRx N.V.. (1/3/19). "Press Release: InflaRx Continues U.S. Expansion with Addition of New York City Corporate Office and Addition of Management". Jena & New York, NY. |
2019-01-03 |
| ADC Therapeutics S.A.. (1/3/19). "Press Release: ADC Therapeutics to Appoint Peter Hug, Ph.D., to Board of Directors". Lausanne. |
2019-01-03 |
| Confo Therapeutics N.V.. (1/3/19). "Press Release: Confo Therapeutics Announces Exclusive, Worldwide License Agreement with VIB for Powerful Novel Structure Determination Technology". Ghent. |
2019-01-03 |
| Rentschler Biopharma SE. (1/3/19). "Press Release: Rentschler Biopharma Completes Acquisition of U.S. Manufacturing Site". Laupheim & Milford, MA. |
2019-01-03 |
| Hookipa Pharma Inc.. (1/2/19). "Press Release: Hookipa Achieves First Research Milestone in HIV Collaboration and License Agreement with Gilead". New York, NY & Vienna. |
2019-01-02 |
| Bruker Corporation. (2/1/19). "Press Release: Bruker Corporation to Present at the 37th Annual J.P. Morgan Healthcare Conference". Billerica, MA. |
2019-01-02 |
| Novartis AG. (12/21/18). "Press Release: Novartis Successfully Completes Acquisition of Endocyte". Basel. |
2018-12-21 |
| Nabriva Therapeutics plc. (12/21/18). "Press Release: Nabriva Therapeutics Announces Closing of up to a $75 million Term Loan". Dublin. |
2018-12-21 |
| Valneva S.E.. (12/21/18). "Press Release: Valneva Awarded FDA Fast Track Designation for Chikungunya Vaccine Candidate". Saint-Herblain. |
2018-12-21 |
| Novartis AG. (12/20/18). "Press Release: Novartis Announces Offer to Acquire CellforCure to Expand Manufacturing Capacity for Innovative Cell and Gene Therapies". Basel. |
2018-12-20 |
| Novartis AG. (12/20/18). "Press Release: Novartis Announces New CEO of Oncology Business Unit". Basel. |
2018-12-20 |
| Bruker Corporation. (12/20/18). "Press Release: Bruker Comments on Block Trade Transaction". Billerica, MA. |
2018-12-20 |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 16 17 18 ... 44 45 46 
Date
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
